NeuroOne Medical Technologies Long Term Debt 2021-2025 | NMTC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NeuroOne Medical Technologies long term debt from 2021 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NeuroOne Medical Technologies long term debt from 2021 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$145.2B
CVS Health (CVS)	$74.3B
Elevance Health (ELV)	$63.1B
Cencora (COR)	$56.3B
DiDi Global (DIDIY)	$26.2B
Labcorp Holdings (LH)	$22.4B
Natera (NTRA)	$19.3B
BioMerieux (BMXMF)	$16B
ICON (ICLR)	$15.7B
EUROFINS SCIENT (ERFSF)	$14.8B
CochLear (CHEOY)	$13.4B
Medpace Holdings (MEDP)	$12.8B
Solventum (SOLV)	$12.8B
Revvity (RVTY)	$12B
Viatris (VTRS)	$11B
Avantor (AVTR)	$9.5B
Sonic Healthcare (SKHHY)	$9.3B
Charles River Laboratories (CRL)	$8.7B
HealthEquity (HQY)	$8.2B
Caris Life Sciences,�Inc (CAI)	$7.5B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.4B
Surgery Partners (SGRY)	$2.7B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.5B
GeneDx Holdings (WGS)	$2.3B
Alignment Healthcare (ALHC)	$2.3B
Progyny (PGNY)	$2B